A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on: February 18,2024

A multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

by Impact Journals LLCOptimization of circulating tumor cells (CTC) staining and validation of p300 activity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28477A new research paper wa

Updated on:February 18,2024

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Updated on: January 23,2024

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Updated on:January 23,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on: April 09,2024

Researchers discover factors that two aggressive cancers have in common

by Leslie Orr,University of Rochester Medical CenterThis image shows how the green cancer cells are protected by the red TAMs. Credit: University of Rochester Medical CenterIndividuals diagnosed

Updated on:April 09,2024

Mainstreaming genetic counselling for ovarian cancer could support screening, in Malaysia and beyond

by European Society for Medical OncologyCredit: European Society for Medical OncologyA study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in

Updated on: April 23,2024

Mainstreaming genetic counselling for ovarian cancer could support screening, in Malaysia and beyond

by European Society for Medical OncologyCredit: European Society for Medical OncologyA study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in

Updated on:April 23,2024

Researchers characterize lung inflammation associated with some cancer immnunotherapy

by Johns Hopkins UniversityCredit: CC0 Public DomainImmune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed as game changing, garneri

Updated on: June 08,2024

Researchers characterize lung inflammation associated with some cancer immnunotherapy

by Johns Hopkins UniversityCredit: CC0 Public DomainImmune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed as game changing, garneri

Updated on:June 08,2024

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST

Updated on: January 30,2024

A new nutrition-screening tool for the oncologic population

byScience China PressVenn plots of three screening tools and malnutrition defined by PG-SGA. Malnutrition was defined as a PG-SGA score of ≥4. The malnutrition risk in MST was defined as an MST

Updated on:January 30,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on: January 04,2024

Oncology therapy at the end-of-life: Have we missed the mark?

by Yale Cancer CenterCredit:JAMA Oncology(2022). DOI: 10.1001/jamaoncol.2022.4666Continued treatment for patients with cancer near end-of-life delays conversations about goals of care and

Updated on:January 04,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on: October 21,2024

Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival

by NRG OncologyCredit: Unsplash/CC0 Public DomainThe addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival fo

Updated on:October 21,2024

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on: February 01,2024

An elusive mechanism of wasting syndrome cachexia revealed

by Justin Jackson , Medical XpressOSM induces Eda2r expression in muscle and the depletion of OSMR protects from muscle wasting. a, Mouse primary myotubes were treated with recombinant TNFα, IL-6, LIF

Updated on:February 01,2024

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari

Updated on: January 30,2024

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari

Updated on:January 30,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on: January 03,2024

Breast cancer: An aggressive variant triggers a hunt for cures

by Vittoria D'alessio,Horizon: The EU Research & Innovation MagazineResearchers are making progress finding treatments for a particularly aggressive variant of breast cancer. Credit: Ang

Updated on:January 03,2024

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca

Updated on: March 20,2024

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca

Updated on:March 20,2024